The pathway of sterol biosynthesis is highly conserved in all eucaryotic cells. We demonstrated structural and functional conservation of the rate-limiting enzyme of the mammalian pathway, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) Analysis of sterol biosynthesis in the yeast Saccharomyces cerevisiae and in mammalian cells (7) led to the biochemical elucidation of this pathway, which produces all isoprene-containing compounds, including sterol, ubiquinone, dolichol, and isopentenylated adenosine in tRNA. The enzymatic steps of this pathway are highly conserved between S. cerevisiae and larger eucaryotes. Although the regulation of this pathway in yeast cells remains virtually unexplored, it has been examined extensively in mammalian cells. These studies have revealed that 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) is the rate-limiting enzyme of the mammalian pathway.
Analysis of sterol biosynthesis in the yeast Saccharomyces cerevisiae and in mammalian cells (7) led to the biochemical elucidation of this pathway, which produces all isoprene-containing compounds, including sterol, ubiquinone, dolichol, and isopentenylated adenosine in tRNA. The enzymatic steps of this pathway are highly conserved between S. cerevisiae and larger eucaryotes. Although the regulation of this pathway in yeast cells remains virtually unexplored, it has been examined extensively in mammalian cells. These studies have revealed that 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) is the rate-limiting enzyme of the mammalian pathway.
The rates of synthesis and degradation of mammalian HMG-CoA reductase are controlled by negative feedback regulation. Serum cholesterol in the form of low-density lipoprotein reduces the steady-state level of HMG-CoA reductase mRNA (14, 32) and also decreases the half-life of the protein (11, 18 ). An unidentified nonsterol product of the pathway provides additional negative feedback regulation (9, 44) . The response of HMG-CoA reductase to the diurnal cycle and to several hormones may be mediated by reversible phosphorylation of the enzyme (6, 55) and by allosteric effectors (49) .
Mammalian HMG-CoA reductase is an integral membrane glycoprotein of the endoplasmic reticulum (8, 34) and has also been identified in peroxisomes (29) . A structural model for the endoplasmic reticulum form of hamster HMG-CoA reductase has been proposed which is based on secondarystructure predictions from the primary sequence and on proteolysis experiments (33) . The NH2-terminal one-third of the protein (amino acids 1 to 339) is membrane bound and contains seven potential membrane-spanning domains and a single N-linked glycosylation site. The COOH-terminal twothirds of the protein (amino acids 340 to 887) extends into the HMG-CoA reductase with membrane is not required for its activity, since a soluble COOH-terminal fragment of the enzyme retains catalytic function in vivo (22) . However, the membrane-bound domain of HMG-CoA reductase is required for regulation of the half-life of the protein by low-density lipoprotein (22) and for the proliferation of smooth endoplasmic reticulum membrane caused by HMGCoA reductase overproduction (2, 12, 27) .
The mammalian genome contains a single gene encoding HMG-CoA reductase (35, 46) . In contrast, yeast cells contain two genes encoding HMG-CoA reductase, designated HMGJ and HMG2 (5) . Cells containing a mutant allele of HMGJ or HMG2 have only a subtle growth defect (4) . However, cells containing mutant alleles of both HMGJ and HMG2 are inviable (5 tion of these functions. Furthermore, conservation of catalytic function was examined directly by testing the ability of mammalian HMG-CoA reductase to function in hmgl hmg2 yeast cells lacking both yeast isozymes.
MATERIALS AND METHODS
Strains, media, and genetic methods. To construct JRY1597 (ot hmgl::LYS2 hmg2::HIS3 lys2-801 his3A200 ura3-52 ade2-101 met), a rare mating between JRY1159 (a hmgl::LYS2 HMG2 lys2-801 his3A200 ura3-52 ade2-101 met) and JRY1160 (a HMGJ hmg2::HIS3 lys2-801 his3A200 ura3-52 ade2-101 met) was performed with selection for His' Lys' diploid cells. The resulting diploid was sporulated on sporulation medium containing mevalonolactone, and asci were dissected into tetrads on YM medium containing mevalonolactone. JRY1597 was obtained as a His' Lys' segregant and required mevalonolactone for growth. Plasmids were introduced into JRY1597 by transformation, with selection for uracil independence. A 333-mg/ml stock solution of DL-mevalonolactone (Sigma Chemical Co.) in water was prepared and used at a concentration of 5 mg/ml. Yeast minimal medium containing 2% glucose (YM) and sporulation medium were prepared as described previously (3) . Amino acid supplements were added, when needed, at a concentration of 30 ,ug/ml. Solid medium contained 2% agar. Standard genetic manipulations were performed as described before (39) . Yeast cells were transformed by the method of Hinnen et al. (25) , except that spheroplasts were prepared with lyticase, a gift from the Schekman laboratory.
DNA sequencing. For sequence analysis, recombinant plasmids were propagated in Escherichia coli DIH101 (constructed by D. Ish-Horowicz; provided by S. Mount), and single-stranded DNA was prepared and sequenced by the dideoxy-terminator method (51) . To sequence HMGJ, two restriction fragments from pJR59 (5) were used. The leftward 2.48-kilobase-pair (kbp) EcoRI fragment was inserted into the EcoRI site of pEMBL18 (constructed by H. Roiha by replacing the polylinker of pEMBL8 [17] with that of pUC18 [41] ) in both orientations, generating pJR301 and pJR302. The rightward 1.71-kbp PstI-EcoRI fragment was treated with T4 DNA polymerase to make both ends blunt, and the fragment was then inserted into the SmaI site of pEMBL18 in both orientations, generating pJR307 and pJR362. pJR301, pJR302, pJR307, and pJR362 were digested with PstI and BamHI, and nested deletions in the insert fragment were created by exonuclease III and S1 nuclease treatment as described before (24) . To determine the sequence between the central EcoRI site and the PstI site, the rightward 1.73-kbp EcoRI fragment was inserted into the EcoRI site of pEMBL18, generating pJR327. Nucleotide sequence was also determined by using oligonucleotide primers complementary to known nucleotide sequences. To sequence HMG2, a 4.90-kbp EcoRI fragment from pJR322 (5) was inserted into the EcoRI site of pEMBL18 in both orientations, generating pJR417 and pJR418. pJR417 and pJR418 were digested with XbaI and PstI, and nested deletions in the insert fragment were created as described for HMGJ.
Sequence from two HindIII sites and from a BamHI site was determined by inserting appropriate restriction fragments into pEMBL18. Nucleotide sequence was also determined by using oligonucleotide primers complementary to known nucleotide sequences.
Plasmid constructions. pJR168 (alias pBM150), obtained from Mark Johnston, contains ARSI, CEN4, the GAL] promoter, and the URA3 gene as a selectable marker (28 [17] with that of pUC19 [41] ) at the corresponding sites, generating pJR419. The 28-base-pair (bp) BamHI-SphI fragment of pJR419 was replaced with a double-stranded fragment formed by annealing two oligonucleotides, 5 To sequence HMGJ, nested deletions were generated as described in the Materials and Methods section. The extent of nucleotide sequence determined from each deletion analyzed is represented by an arrow. The extent of nucleotide sequence determined from pJR327 is represented by an arrow drawn with a solid circle. The extent of nucleotide sequence determined by using oligonucleotide primers complementary to known nucleotide sequence is represented by an arrow drawn with an asterisk. (B) To sequence HMG2, nested deletions in the insert fragment were created as described for HMGJ. The extent of nucleotide sequence determined from each deletion analyzed is represented by an arrow. The extent of nucleotide sequence determined from two Hindlll sites and from a BamHI site is represented by arrows drawn with a solid circle. The extent of nucleotide sequence determined by using oligonucleotide primers complementary to known nucleotide sequence is represented by arrows drawn with an asterisk. Ba, BamHI; Bg, Bglll; E, EcoRI; H, HindlIl; P, PstI; X, XbaI.
at the first methionine codon. A comparison of the amino acid sequences of the HMG1 and HMG2 proteins with each other and with the COOH-terminal region of human HMGCoA reductase (36) is shown in Fig. 3 . The sequences of the three proteins have been aligned to maximize their sequence similarity.
Model for the secondary structure of the HMG1 protein. To examine the structural similarities of the HMG1 protein with mammalian HMG-CoA reductase, we constructed a model for the secondary structure of the HMG1 protein. The methods and parameters used are outlined in the legend to Fig. 4 . The secondary structures of the human and hamster proteins are predicted to be virtually identical, reflecting their high degree of sequence similarity: only 32 nonconservative amino acid replacements exist between the two proteins (10, 36) . In contrast, there were many amino acid differences between the yeast and mammalian enzymes. The predicted structure of the NH2-terminal half (amino acids 1 to 529) of the HMG1 protein is presented in Fig. 4A , and the predicted structure of the COOH-terminal half (amino acids 530 to 1054) is presented in Fig. 4B .
Comparison of hydrophobicity plots of the HMG1 and hamster HMG-CoA reductase proteins ( Fig. 5A and B) showed that the NH2-terminal region of both proteins was in general much more hydrophobic than the COOH-terminal region. Both NH2-terminal regions exhibited the alternating hydrophobic and hydrophilic regions characteristic of membrane-bound domains containing several transmembrane helices. Moreover, both NH2-terminal regions met the criteria for the prediction of membrane-bound domains suggested by Eisenberg et al. (19) : both had at least one very hydrophobic stretch of 21 amino acids, which would highly favor a membrane environment, and both also contained several other moderately hydrophobic stretches whose hydrophilic groups would cluster on one side of an a-helix.
Eight potential membrane-spanning helices were identified in the hydrophobicity plot of the putative membrane-bound domain of the HMG1 isozyme. As shown in Table 1 , these potential helices were evaluated in terms of overall hydrophobicity, amphipathicity, membrane propensity, and length (30, 45) . We applied a predictive algorithm based on the length and membrane propensity of each of the putative membrane-spanning domains, as suggested by Rao and Argos (45) . This algorithm has been shown to be fairly effective in distinguishing membrane-spanning helices from hydrophobic regions in soluble proteins (45) , and it distinguished the seven long hydrophobic stretches in the membrane-bound domain from the predicted hydrophobic Ibarrels of hamster HMG-CoA reductase. However, a very hydrophobic 20-residue stretch at the COOH-termini of both hamster HMG-CoA reductase and the HMG1 isozyme was strongly predicted to be a membrane-spanning region by this algorithm and all other criteria we considered, even though this stretch is part of a domain which appears to be soluble after proteolysis (33) .
The six most hydrophobic of the eight potential membrane-spanning helices of the HMG1 isozyme, the regions labeled 1, 2, 4, 6, 7, and 8 in Fig. 4A , were strongly predicted to span the membrane. Regions 3 and 5, in contrast, had overall hydrophobicities at the lower end of the range observed for membrane-spanning helices, and both had large hydrophobic moments more characteristic of helices in globular proteins (Table 1) (19) . Region three comprised the 29 amino acids between predicted membrane-spanning regions 2 and 4 and contained several moderately hydrophilic residues, such as serine, and two charged residues. This region was rather short for forming a membrane-spanning helix and two spacer regions and was therefore tentatively represented as a spacer region between helices 2 and 4. The COOH-terminal half of region 5 was very hydrophobic, but the NH2-terminal half contained five charged residues which would lie on one side of the helix. It would therefore be rejected as a membrane-spanning helix by the rules of Rao and Argos (45) . However, a clustering of charged residues on the cytoplasmic side of membrane-spanning helices has GluArgValSerLeuProAspPheIleThrSerA3nAlaSerGluA,snPheLyaGluGlnAlaIleValSerValThrProLeuLeuTyrTyrLy3ProIleLysSerTyrGlnArgIle 480 been observed in the reaction center complex from the purple photosynthetic bacterium Rhodopseudomonas viridis (38) . We have therefore tentatively represented region 5 as a membrane-spanning region.
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The hydrophobicity plot of the HMG2 protein (Fig. SC ) was very similar to that of the HMG1 protein. Moreover, the predicted secondary structure of the NH2-terminal half of the HMG2 protein contained seven membrane-spanning domains arranged in nearly identical positions as they are in the HMG1 protein and with similar characteristics (Table 1) . Inspection of the sequence similarity between the NH2-terminal halves of the HMG1 and HMG2 proteins revealed that the potential membrane-spanning domains were in general more conserved than the spacer regions between them (Fig. 6) . However, individual spacer regions can differ markedly in the extent of their conservation. For example, the long spacer region between membrane-spanning domains 1 and 2 was weakly conserved, whereas the spacer region between membrane-spanning domains 5 and 6 was highly conserved (Table 2) .
If it is assumed that the catalytic domain of yeast HMGCoA reductase, like that of the hamster enzyme to which it is very similar, lies on the cytoplasmic side of the membrane, then the spacer region between the last two membranespanning domains can be reliably predicted to lie on the luminal side of the membrane. In this spacer region in both the HMG1 and HMG2 isozymes, two consensus sequences for N-linked glycosylation sites were found, although these sites were not conserved between the two proteins (amino acids 452 and 490 and amino acids 428 and 455 of the HMG1 and HMG2 proteins, respectively). Likewise, the single glycosylation site of the human and hamster enzymes also lay between the last two predicted membrane-spanning regions. Several other potential N-linked glycosylation sites were found in the membrane-bound domains of the HMG1 and HMG2 isozymes, as shown in Fig. 3 .
Although the NH2-termini of both the yeast and human proteins were predicted to contain seven membrane-spanning regions, no primary sequence similarity was observed in this region between either of the yeast proteins and the human protein. However, the predicted membrane-spanning domains of the yeast and human proteins were similar in that they contained amino acids that are usually charged. As noted previously (33), these charged residues might allow ion pairing within or between packed helices. Another similarity between the yeast and human NH2-terminal regions was that, in both proteins, the spacer regions between the membrane-spanning domains were predicted to contain amphipathic helices which could associate with the lipid bilayer so that the hydrophobic face would be embedded in the interior of the bilayer and the hydrophilic face would (31) . A Fourier transform analysis designed to detect periodicities in hydrophobicity that suggest the presence of amphipathic a-helix or p-pleated sheet structure was used to identify regions of secondary structure (20) . The algorithm of Gamier et al. (21) , based on the frequency with which amino acids form different secondary structures in X-ray crystal structures, was also used. Charged amino acids are indicated by + or -. Cysteine residues are indicated by S, glycine residues by G, and proline residues by P. The hydrophobicity of each residue, averaged over a window of 21 amino acids by the method of Kyte and Doolittle (31) , is plotted as a function of residue number. (A) Hamster HMG-CoA reductase, redrawn from Liscum et al. (33) . The seven predicted membranespanning domains are labeled 1 to 7. The regions labeled bl and b2 are predicted to have a-structure and contain hydrophobic stretches. The corresponding regions of the HMG1 and HMG2 proteins predicted to have the same structure are similarly labeled (see Fig. 4 ). (B) HMG1 protein. Of the eight peaks of hydrophobicity (labeled 1 to 8), all except peak 3 are predicted to span the membrane (see Fig. 4 ). (C) HMG2 protein.
in amphipathic helices in the linker regions of both the yeast and mammalian proteins.
The COOH-terminal regions of the HMG1 and HMG2 proteins were highly conserved with respect to both mammalian HMG-CoA reductase and each other. Amino acids 667 to 1025 of the HMG1 protein were 65% identical and 25% conserved with amino acids 512 to 871 of human HMG-CoA reductase. Amino acids 618 to 1026 of the HMG1 protein were 93% identical and 3% conserved with amino acids 614 Fig. 4A . The predicted membrane-spanning helices of hamster HMG-CoA reductase are described in Liscum et al. (33) .
b Average hydrophobicity over most-hydrophobic 21-residue stretch calculated with the normalized consensus hydrophobicity scale of Eisenberg et al. (19) .
c Hydrophobic moment over the 11-residue stretch with the most pronounced helical periodicity, calculated as described in Eisenberg et al. (19) .
d Height of peak in buried-helix-parameter plot described by Rao and Argos (45) .
e Width of peak in buried-helix-parameter plot at baseline of 1.05 (45) .
to 1022 of the HMG2 protein. The COOH-terminal region of these three proteins was the most conserved of any region within the protein. This strong sequence similarity suggests that the catalytic domain of the yeast isozymes, like that of the mammalian enzyme, is contained within this COOHterminal region.
The predicted secondary structure of the COOH-terminal region of the HMG1 protein (Fig. 4B) closely resembled that of the hamster protein. This region was predicted to consist largely of amphipathic helices flanking extended p-pleated sheet structure. As noted previously (33) , it seems likely that residues from the putative p-domains form at least part of the active site. Regions of weak sequence similarity between the HMG1 and hamster proteins, indicated by dashed lines in Fig. 4B , fell in loops adjacent to p-strands or in amphipathic helices, as would be expected if the domains from the two proteins had similar tertiary structures. Thus, the predicted amphipathic helical structure is strongly conserved even when primary sequence is only weakly conserved.
The reaction by which HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate may involve the transient protonation of a histidine residue (47) . Of the seven histidines conserved between the COOH-terminal regions of the two yeast proteins, four were also conserved with human HMG-CoA reductase at residues 909, 1015, 1020, and 1023 of the HMG1 protein.
In contrast to the general sequence similarity in the Table 2 , footnote a.
COOH-terminal regions of the two yeast isozymes to each other and to the human enzyme, no obvious sequence similarity existed between the final 28 residues of the HMG1 protein with either the HMG2 or human protein. Although the significance of this sequence divergence is unclear, we note that the sequences located at the COOH-terminus of both of the yeast enzymes as well as the hamster and human enzymes contained cysteine residues that could be used as sites for posttranslational fatty acid acylation (53) , as is the case for several other integral membrane proteins, such as the G protein of vesicular stomatitis virus (50), the transferrin receptor (26) , and rhodopsin (42 a Two amino acids are considered conserved if they are found together in one of the following classes: (i) alanine, valine, leucine, isoleucine, proline, phenylalanine, tryptophan, methionine, glycine, cysteine; (ii) serine, threonine, cysteine, tryosine, asparagine, glutamine; (iii) aspartic acid, glutamic acid; (iv) lysine, arginine, histidine; (v) phenylalanine, tyrosine, tryptophan; (vi) histidine, tryptophan (15, 16, 40) .
b Amino acids are numbered as for the HMG1 protein. The alignment of the HMG1 and HMG2 proteins is shown in Fig. 3 .
c Transmembrane domains are numbered sequentially. Note that transmembrane domains 3 through 7 correspond to regions 4 through 8 in Fig. 4 and 5.
gene or to cDNA clones encoding either hamster or human HMG-CoA reductase. The GAL) promoter was inactive when cells were grown in glucose-containing medium, but active when cells were grown in galactose-containing medium. These plasmids were introduced separately into an hmgl hmg2 strain by transformation and tested for their ability to alleviate the mevalonate auxotrophy of this strain in galactose-containing medium.
As shown in Fig. 7 (35, 46) . No pseudogenes have been identified. The observation that yeast cells contain two genes encoding HMG-CoA reductase suggests that these two genes arose from the duplication of a single gene after the divergence of S. cerevisiae and mammals. We can make a minimum estimate of the time since this duplication event took place by considering the sequence divergence between the linker regions of the HMG1 and HMG2 proteins. As no similarity between these two regions was detected, we estimate that these regions have diverged by at least 90%. Assuming a divergence rate of 0.7 million years for each percent sequence divergence for sequences not under selection (54) , then 90% sequence divergence would occur over 63 million years. However, it seems likely that the linker region is under some selective pressure. Comparison of the linker regions of human and hamster HMG-CoA reductase (36) indicates a divergence rate of 2.2 million years for each percent sequence divergence. This estimate of the rate of divergence of the linker regions would require that the duplication event generating HMGJ and HMG2 occurred at least 198 million years ago.
The ancient divergence of yeasts and mammals has allowed sequences not under stringent selective pressure to diverge completely. The only sequence similarity shared between yeast and mammalian HMG-CoA reductase occurs in the region of the protein expected to be under the most stringent selection, the catalytic domain. One explanation for the lack of sequence similarity observed between the membrane-bound domains of the yeast and mammalian enzymes is that the selective pressure maintaining the primary sequence of this domain has not been sufficient to prevent complete sequence divergence from a common ancestral gene. Alternatively, HMG-CoA reductase may first have evolved as a soluble enzyme that acquired membrane-bound NH2-termini of roughly the same structure independently in yeasts and mammals after their divergence.
Although the COOH-terminal region, containing the catalytic domain, is generally conserved between the yeast and mammalian proteins, no sequence similarity is observed in the final amino acids of these proteins. Intriguingly, the position of an intron in the hamster gene marks the boundary of similarity between the yeast and hamster proteins. Intron 19 splits the codon for amino acid 870 of the hamster protein (46) . This residue is the last to have sequence similarity with the yeast proteins, 29 amino acids from the end of the HMG1 protein and 24 
